One study found that gastric cancer patients with PIK3CA, LRP1B and AHNAK2 mutations had a better prognosis, and that investigating the molecular mechanisms of the three-gene interaction has potential value in improving the prognosis of gastric cancer (91). The gene discussed is AHNAK2; the disease is gastric cancer.